Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Capbio is an innovative biotechnology company specializing in high-resolution spatial proteomics and protein-protein interaction (PPI) mapping. The company's core technology, Chemical-Assisted Proximity labeling (CAP), enables the precise identification of protein neighborhoods and transient interactions within living cells and tissues. Capbio provides a comprehensive suite of products and services, including CAP-tag and CAP-labeling kits, to facilitate drug target discovery, mechanism of action studies, and the development of precision therapeutics. By bridging the gap between genomics and functional proteomics, Capbio aims to accelerate the discovery of novel biomarkers and therapeutic targets across various disease areas, including oncology and neurobiology.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Capbio.